Open AccessRole of statin in increasing the risk of diabetes mellitus
Author(s) -
Mahdi Mohammadian,
Hamid Salehiniya,
Jamshid Ovisey,
Fatemeh Allah Bakeshei,
Abdollah Mohammadian-Hafshejani
Publication year - 2017
Publication title -
biomedical research and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 1
ISSN - 2198-4093
DOI - 10.15419/bmrat.v4i12.391
Subject(s) - medicine , diabetes mellitus , statin , type 2 diabetes mellitus , blood sugar , drug , type 2 diabetes , stroke (engine) , pharmacology , endocrinology , mechanical engineering , engineering
Statin is known as one of the most commonly prescribed medicines in the United States (Bhattacharya et al., 2014). This drug is widely used with the aim to prevent risk of stroke and cardiovascular diseases as well as reduction of mortality from these diseases (Mohammadian et al., 2015; Ong et al., 2014). Several studies have recently paid attention to roles of Statins in increasing the risk of type 2 diabetes mellitus. Based on results of several clinical trials on prevention of cardiovascular diseases, Statin leads to an increased risk of type 2 diabetes mellitus (T2DM) (Crandall et al., 2017). This drug leads to an increase at fasting blood sugar, glycosylated hemoglobin (HbA1c) and blood sugar levels in recipients (Mohammadian et al., 2017; Ridker et al., 2012).